Literature DB >> 27683971

Stroke due to non-bacterial thrombotic endocarditis as initial presentation of breast invasive ductal carcinoma.

Celine Detremerie1, Frank Timmermans1, Michel De Pauw1, Peter Gheeraert1, Dimitri Hemelsoet1, Jonas Toeback1, Thierry Bové1, Els Vandecasteele1.   

Abstract

We present a case of a 71-year-old woman with recurrent stroke episodes due to non-bacterial thrombotic endocarditis (NBTE) leading to the diagnosis of an early-stage breast carcinoma. NBTE is associated with a variety of inflammatory states, including malignancy. NBTE presents itself with systemic embolization, mostly stroke. Treatment consists of treating the underlying condition and start of systemic anticoagulation therapy. Cardiac surgery is restricted to highly selected cases, since prognosis usually is limited by the neoplasm, which usually is in an advanced stage at time of diagnosis of NBTE. The malignancy usually is diagnosed prior to NBTE. Cases presenting with NBTE leading to the diagnosis of malignancy, however, are rarely reported. To our knowledge, we present the first case leading to the diagnosis of an early-stage breast carcinoma.

Entities:  

Keywords:  Breast carcinoma; Marantic endocarditis; Non-bacterial thrombotic endocarditis (NBTE); Stroke

Mesh:

Year:  2016        PMID: 27683971     DOI: 10.1080/17843286.2016.1219012

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  2 in total

Review 1.  Cancer and Cerebrovascular Disease.

Authors:  Harold P Adams
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-23       Impact factor: 5.081

Review 2.  Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach.

Authors:  Malin Woock; Nicolas Martinez-Majander; David J Seiffge; Henriette Aurora Selvik; Annika Nordanstig; Petra Redfors; Erik Lindgren; Mayte Sanchez van Kammen; Alexandros Rentzos; Jonathan M Coutinho; Karen Doyle; Halvor Naess; Jukka Putaala; Katarina Jood; Turgut Tatlisumak
Journal:  Ther Adv Neurol Disord       Date:  2022-06-28       Impact factor: 6.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.